Most won’t consider sleep disorder a serious kinda ailment, but in many cases it can be worse than most bodily disorders. A few of the symptoms include “feeling like death,” exhaustion, irritability, and a slow gait. So, the patients behave almost like zombies.
That’s why the Better Sleep Council (BSC), as part of its Stop Zombieitis! campaign, recently decided to inform the public about the sleep deprivation epidemic. The BSC would contact “unslept” zombies online and provide them with information about the Zombieitis epidemic and its cure. (Read: Efforts Are On to Cure Unslept Zombies)
And now Philips Respironics, a unit of Royal Philips Electronics, is working on the future of sleep therapy. It is offering a technology solution for treating and managing obstructive sleep apnea (OSA) – in an advanced CPAP (Continuous Positive Airway Pressure) device.
The new REMstar Pro with AutoIQ is a prime example of an intelligent solution that allows providers and physicians to deliver exceptional care while helping their patients take control of their sleep therapy, the company suggests.
The new AutoIQ mode has the ability to track a patient’s progress over several nights, establish or readjust to an ideal therapy pressure, and check back periodically to reassess and adjust treatment as needed. This is all done without requiring the provider to visit the patient’s home.
There are two distinct phases of the AutoIQ mode: Auto-Trial and Auto-Check. The first phase, Auto-Trial, uses the Philips Respironics auto algorithm for periods of three days or more, adding up to a total of 30 days, to deliver breath-by-breath therapy and learn the patient’s treatment needs.
Auto-Trial days can be saved to reassess therapy at a later date should the patient’s condition or characteristics change, such as weight gain or a change in sleeping environment.
At the end of the Auto-Trial phase, the device analyzes the data to identify and automatically deliver the ideal pressure for that patient. It can also deliver a fixed pressure that has been set by the clinician.
Once the ideal pressure is established for the patient, Auto-Check, the second phase of the AutoIQ mode, checks back every 30 hours to see how the patient is progressing with therapy. This phase determines if a pressure change is needed and automatically adjusts the pressure (within the limits set by the clinician) to meet therapeutic needs.
Throughout the entire process, AutoIQ keeps the care team informed with key compliance information. The REMstar Pro with AutoIQ mode provides new levels of intelligence, control and convenience for sleep therapy, says the company.
Covering diverse segments of activity, RMN News Service discusses the burning issues that have immediate impact on various governments, businesses, and the lives of commoners.
Raman Media Network (RMN) Company is a leading integrated technology media and entertainment company. It is working in diversified content creation, management, and distribution businesses on a global scale.